Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.
Mice that received an anti-interleukin-10 (anti-IL-10) neutralizing monoclonal antibody (MAb) (SXC-1) prior to infection with Listeria monocytogenes initially demonstrated resistance to the infection, as indicated by reduced recovery of L. monocytogenes from their spleens and livers during the first...
Guardat en:
| Publicat a: | Infect Immun |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186517/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8188357/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.62.6.2345-2353.1994 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|